National Health Stock Target Price and Analyst Consensus
| NHI Stock | USD 75.10 1.73 2.36% |
The current analyst and expert consensus on National Health is Buy with 4 hold recommendations. The current projected National Health target price consensus is 79.57 with 8 analyst opinions. One of the most common ways National Health Investors analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to National Health vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on National Health. We strongly encourage you to use your own analysis of National Health Investors to validate this buy or sell advice. National Health recommendation module provides expert sentiment on the projected National Health Investors target price to derive its highest and lowest estimates based on target price standard deviation of 1.4911.
Lowest Forecast 72.41 | Highest Forecast 88.32 | Target Price 79.57 |
National |
It's important to approach National Health's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
National Health Target Price Consensus
National target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. National Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 8 | Buy |
Most National analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand National stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of National Health Investors, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationNational Health Target Price Projection
National Health's current and average target prices are 75.10 and 79.57, respectively. The current price of National Health is the price at which National Health Investors is currently trading. On the other hand, National Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
National Health Market Quote on 15th of March 2025
Target Price
Analyst Consensus On National Health Target Price
National Health Analyst Ratings
National Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about National Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of National Health's financials, market performance, and future outlook by experienced professionals. National Health's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize National Health price targets
National Health's stock target price is an estimate of its future price, usually made by analysts. Using National Health's target price to determine if it is a suitable investment can be done through the following steps:- Look at National Health's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if National Health's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional National Health Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of National Health is a key component of National Health valuation and have some predictive power on the future returns of a National Health.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Momentum Invested few shares | |
 | Driverless Cars Invested over 60 shares | |
 | Macroaxis Picks Invested few shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Macroaxis Index Sold over 90 shares | |
 | Basic Utilities Invested over 90 shares | |
Check out Macroaxis Advice on National Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.